Cohen Neil Harris bought CMMB
July 16, 2020 · Form 4 insider transaction
Cohen Neil Harris bought 172 shares of Chemomab Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2238 days after the transaction.
Direction
Acquired (buy-side)
Shares
172
Price
$0.00
Total value
N/A
InsiderCohen Neil Harris
Role—
SecurityStock option (right to buy American Depositary Shares)
Transaction codeA: Grant or award
Transaction dateJuly 16, 2020
Filing dateSeptember 1, 2026
Shares owned after172
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report.